The secrets behind GSK's strategic sauce
This article was originally published in Scrip
Executive Summary
Brian McVeigh says that GlaxoSmithKline PLC is in a unique position amongst its pharma peers; instead of scrambling to fill its late-stage pipeline, it is working to build the pipeline after that, and the pipeline after that.